Helen M Macdonald, Fiona E McGuigan, Susan A Lanham-New, William D Fraser, Stuart H Ralston, and David M Reid

Size: px
Start display at page:

Download "Helen M Macdonald, Fiona E McGuigan, Susan A Lanham-New, William D Fraser, Stuart H Ralston, and David M Reid"

Transcription

1 Vitamin K 1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphisms 1 4 Helen M Macdonald, Fiona E McGuigan, Susan A Lanham-New, William D Fraser, Stuart H Ralston, and David M Reid ABSTRACT Background: Polymorphisms in the apolipoprotein E (APOE) gene are associated with fracture risk, and a potential mechanism is through vitamin K transport. Objective: We investigated the relation between dietary vitamin K 1 intake, APOE polymorphisms, and markers of bone health. Design: We measured bone mineral density (BMD) at the lumbar spine (LS) and femoral neck (FN) in a cohort of Scottish women aged y in (baseline) and in (visit 2). At visit 2, bone markers (urinary pyridinoline crosslinks and serum N-terminal propeptide of type 1 collagen) were measured, 3199 women completed a food-frequency questionnaire, and 2721 women were genotyped for APOE. Results: Compared with quartile 3 (Q3) of energy-adjusted vitamin K 1 intake (x : 116 g/d), women in the lowest quartile (x : 59 g/d) had lower BMD (analysis of variance; FN, Q1: g/cm 2 ; Q3: g/cm 2 ; P 0.001; LS, Q1: g/cm 2 ; Q3: g/cm 2 ; P 0.009), remaining significant at the FN after adjustment for age, weight, height, menopausal status or use of hormone replacement therapy, socioeconomic status, and physical activity (P 0.04). Vitamin K 1 intake was associated with reduced concentrations of pyridinoline crosslinks (Q1: nmol/mmol; Q4: nmol/mmol; P 0.003). Carriers of the E2 allele had greater LS BMD at visit 2 and lost less BMD than did carriers of the E4 allele (E2: %/y; E4: %/y; P 0.05). After adjustment for confounders, the P value for BMD loss (0.03 for LS and 0.04 for FN) did not reach the level of significance required for multiple testing (P 0.012). No interaction was observed between dietary vitamin K and APOE on BMD. Conclusions: Vitamin K 1 intake was associated with markers of bone health, but no interaction was observed with APOE alleles on BMD or markers of bone turnover. Am J Clin Nutr 2008;87: INTRODUCTION The apolipoprotein E (APOE) gene has 3 alleles: E2, E3, and E4, defined by 2 common polymorphisms that affect the protein coding sequence. The E4 allele was associated with increased risk of heart disease, strokes, and diabetes (1), with Alzheimer disease, and with greater fracture risk in a number of populations (2), although the association was not consistent across studies (3, 4). One explanation for the increased fracture risk is that APOE is involved in vitamin K transport in the blood and that less vitamin K is available in carriers of the E4 allele than with carriers of the other alleles because of lower plasma ApoE concentrations. Vitamin K is required for carboxylating osteocalcin. Concentrations of undercarboxylated osteocalcin were associated with increased risk of hip fracture (5, 6), and lower concentrations of circulating vitamin K were found in women with osteoporotic fractures (7, 8). Short-term supplementation with vitamin K corrected the undercarboxylation of osteocalcin in women with Colles fractures (9). The anticoagulant drug warfarin competitively inhibits vitamin K, but studies of warfarin on bone mineral density (BMD) have produced conflicting results, and there is no evidence that warfarin increases fracture rates in women (10). Currently, there are no reference nutrient intakes for vitamin K in the United Kingdom, but a daily intake of 1 g/kg body weight is both safe and adequate (11). The term vitamin K encompasses phylloquinone (vitamin K 1 ) and menaquinone (vitamin K 2 ). Menaquinone is produced by bacteria in the bowel and can originate from fermented foods (12). Its contribution to a Western diet is low. A recent meta-analysis of vitamin K and fracture included only vitamin K 2 and at pharmacologic values (generally g/d) (13). Vitamin K 1 is the major circulating form and the dominant form found in bone (14). A major source of vitamin K 1 is green leafy vegetables (a 100-g portion provides 1 From the Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom (HMM, FEM, and DMR); the Centre for Nutrition and Food Safety, School of Biomedical and Molecular Sciences, University of Surrey, Guildford, Surrey, United Kingdom (SAL-N); the Department of Clinical Biochemistry, Royal Liverpool University Hospital, Liverpool, United Kingdom (WDF); and the Rheumatic Diseases Unit, Molecular Medicine Centre, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom (SHR). 2 Any views expressed are those of the authors. 3 Supported by the UK Food Standards Agency (N 05043) and the Arthritis Research Campaign for continuing infrastructure support (DMR). 4 Reprints not available. Address correspondence to HM Macdonald, Osteoporosis Research Unit, Health Sciences Building, University of Aberdeen, Foresterhill,Aberdeen,AB252ZD,UnitedKingdom. h.macdonald@ abdn.ac.uk. Received July 17, Accepted for publication January 16, Am J Clin Nutr 2008;87: Printed in USA American Society for Nutrition 1513

2 1514 MACDONALD ET AL 200 g vitamin K 1 ) and some vegetable oils. Fruit and vegetable intake was consistently associated with improved bone health status in populations from the United States and the United Kingdom (15 17). Although a plausible hypothesis receiving much renewed attention is that fruit and vegetables protect against excessive bone resorption by providing alkaline metabolites to balance the acidity caused by eating a diet rich in protein (18), an alternative explanation is that fruit and vegetables are beneficial because of the nutrients they provide such as vitamin K 1. Nutrient interactions were reported between alcohol intake and APOE genotype on LDL concentrations (19) and between polyunsaturated fatty acid intake and APOA1 genotype on HDL cholesterol (20). Yan et al (21) showed that higher concentrations of vitamin K 1 were associated with E4 genotype in older persons in China and the United Kingdom. However, to the best of our knowledge, no one has specifically tested for an interaction between APOE genotype and dietary vitamin K in relation to bone health. The aim of this study was to determine whether APOE polymorphisms and dietary intake of vitamin K 1 are associated with markers of bone health in Scottish early postmenopausal women and whether there is an interaction between the vitamin K 1 intake and APOE genotype on early postmenopausal bone loss. SUBJECTS AND METHODS Subjects The subjects for this study were taken from a population-based screening program for osteoporotic fracture risk, involving 5119 women aged y, that took place between 1990 and 1994 with further assessment for 3883 of the women between 1997 and 2000 (22). Blood and urine samples were collected at the second visit only. A subset of 898 women completed a food-frequency questionnaire (FFQ) at both visits, and an additional 2340 women completed the FFQ shortly after the follow-up visit so that there were 3238 completed FFQs in total at visit 2. In 16 subjects, data on weight and hip or spine BMD were missing, and 23 subjects were excluded from the analysis because of extreme daily energy intakes 3.2 MJ and 18 MJ. In total 2731 women were genotyped for APOE polymorphism (of whom 10 had missing weight, hip, or spine data), and 2471 women had information on both diet and APOE genotype for study of APOE-nutrient interaction. At the time of the second visit when women were asked about their current medication, 6 women reported being on anticoagulant therapy. The women were weighed on both occasions wearing light clothing and no shoes on a set of balance scales (Seca, Hamburg, Germany) calibrated to 0.05 kg. Height and sitting height were measured with a stadiometer (Holtain Ltd, Crymych, United Kingdom). Information was collected on general health (whether the subject had a disease), smoking (past, current, and never and how many cigarettes were smoked over how many years), menopausal status (regularity of menstrual periods or date of last menstrual period), and use of hormone replacement therapy (HRT; times started and stopped therapy) and other medication (what medication was currently being taken). Written informed consent was obtained for all the women, and the study was approved by Grampian Research Ethics Committee. Genotyping Genomic DNA was amplified by the polymerase chain reaction (PCR) with the use of the Qiagen Taq polymerase system and primers APOE forward (AGA CGC GGG CAC GGC TGT) and APOE reverse (CTC GCG GAT GGC GCT GAG). The reaction mixture consisted of 2.5 L 10x Q buffer, 2 L deoxyribonucleotide triphosphates at 2.5 mmol/l each, 5 L of Q solution, 0.5 L of each forward and reverse primer (10 mol/l), LQTaq (5 u l 1 ) and 2.5 L genomic DNA 20 ng L 1 made up to 25 L with L sterile water. The samples were thermocycled on a DYAD DNA Engine (MJ Research Inc, Waltham, MA) as follows: denaturation at 95 C for 5 min followed by 50 cycles of denaturation at 95 C for 30 s, annealing at 62 C for 30 s, and extension at 72 C for 30 s with a final extension cycle of 72 C for 5 min. The PCR product (6 L) was cleaned to remove any unused deoxyribonucleotide triphosphates and primers that would interfere in the sequencing reaction with the use of ExoSAP-IT (USB Corp, Cleveland, OH), which contains exonuclease 1 and shrimp alkaline phosphatase. The samples were labeled for sequencing by adding 2 L of DYEnamicET terminator reagent premix (Amersham Biosciences, Amersham, United Kingdom) and 1 L of the forward primer (2.5 mmol/l) to each aliquot of 7 L of purified PCR product and then cycled for 31 cycles by the following steps: 95 C for 20 s, 60 C for 15 s, and 65 C for 1 min. The labeled PCR products were ethanol-precipitated. The sequencing reactions were analyzed on the Amersham Biosciences MegaBACE 1000 DNA Analysis System with the use of downstream base caller (Cimarron 3.12), and the base-called sequences were viewed with the use of the SEQ MAN II expert sequence analysis software (version 5.07; DNASTAR Inc, Madison, WI). The single nucleotide polymorphisms (SNPs) were called individually from the sequence and analyzed according to the genotype of the SNPs situated in the codons at amino acid positions 112 and 158. Both SNPs had C/T base changes with TGC coding for cysteine and CGC coding for arginine. For E3 there is a cysteine in position 112 and arginine in position 158; E2 has a cysteine in both positions; and E4 has an arginine in both positions. Markers of bone health BMD of the left femoral neck (FN) and lumbar spine (LS; L2 L4) was measured by dual-energy X-ray absorptiometry. At baseline all women were measured on the same Norland scanner (Cooper Surgical Inc, Trumbull, CT). At follow-up, most of the women were scanned again with the use of a Norland XR26; however, 12% of women had measurements on the XR36 model. Because the XR36 machine gave slightly higher readings (1.258%), a correction factor was applied to bring these measurements in line with the XR26 measurements. A second, early morning fasting urine sample, collected 2 h after first void, was provided at the second visit only for analysis of free pyridinoline (fpyd) crosslinks and free deoxypyridinoline (fdpd) crosslinks by HPLC (23, 24). Creatinine was measured in urine by standard automated techniques (Roche, Lewes, United Kingdom), and results were expressed as fpyd/creatinine and fdpd/creatinine (in nmol/mmol). Serum N-terminal propeptide of type 1 collagen was measured with the use of an enzyme chemiluminescent immunoassay supplied by Roche Products Ltd (Penzberg, Germany) (25).

3 APOE, VITAMIN K, AND BMD IN POSTMENOPAUSAL WOMEN 1515 Diet and physical activity Dietary assessment was made at the follow-up visit with the use of an FFQ that was validated with the use of 7-d weighed intakes [correlation coefficients (r) ranging from 0.31 for vitamin D, 0.40 for iron, 0.66 for phosphorus, 0.52 for calcium, 0.78 for potassium, 0.61 for protein, 0.81 for vitamin C, and 0.82 for fiber, with 45 90% correctly classified to within 1 quintile] (26) and serum concentrations of antioxidants (r 0.14 for vitamin A and 0.42 for vitamin C, with 68 89% of subjects correctly classified within 1 tertile) (27). A subgroup of women (n 898) also completed the same FFQ at baseline. For most women there was little change in nutrient intake, although mean ( SD) energy intake had decreased from MJ/d to MJ/d (28). Vitamin K 1 concentrations were obtained by analyzing the FFQ with the use of a UK database, compiled by Bolton-Smith et al (29), which specifically detailed the vitamin K 1 content of foods listed in our FFQ. Physical activity levels (PALs) were obtained with the use of the same questions as used for the Scottish Heart Health Study (30). The PAL was calculated from the numbers of hours in a 24-h period doing heavy, moderate, or light activities and how many hours were spent sleeping or resting in bed. These questions were asked separately for working and nonworking days. PAL is normally defined as the ratio of energy expenditure divided by the basal metabolic rate, which is calculated from Schofield equations (31). Statistical analysis Analyses were performed with the use of SPSS version 14.0 (SPSS Inc, Chicago, IL). Dietary vitamin K 1 intakes were adjusted for dietary energy intake by the residual method (32). Categorization of nutrient intake was carried out because this is a particularly appropriate method for analysis of FFQ data. For comparison of the 3 APOE alleles, the approach used by Corella et al (19) was adopted, which categorized the 6 possible genotypes for APOE into 3 groups as follows: carriers of E2 (E2/E2 and E2/E3), carriers of E4 (E4/E4 and E3/E4), and the E3/E3 genotype, omitting the E2/E4 genotype from the analysis (because this genotype could belong to either the E2 or the E4 carrier group). Because a number of independent tests were performed, this raises the possibility of false-positive associations. We took into account the correlation of the BMD sites (r 0.66), and 6 tests resolve into 4.15 independent tests, so that a significance level of would be equivalent to P One-factor analysis of variance (ANOVA; with Scheffe post hoc test) and analysis of covariance (adjusting for confounding variables) were used to examine differences in characteristics and bone health indexes between different genotypes and quartiles of energy-adjusted dietary intake of vitamin K 1. Chisquared tests were used for categorical variables. Stepwise linear multiple regression analysis was used to determine independent predictors, including energy-adjusted dietary vitamin K 1 as a continuous variable, of bone resorption markers and BMD. Dummy variables for menopausal status (premenopausal, perimenopausal, postmenopausal not using HRT, and postmenopausal with past use of HRT) were used to account for menopausal status or HRT use (with current HRT use as the reference). Interaction between genotype and vitamin K 1 was tested by including the following variables in the general linear model: genotype (as carriers of the E2 allele compared with noncarriers of the E2 allele), energy-adjusted intake of vitamin K 1, and an additional multiplicative term of genotype with energy-adjusted intake of vitamin K 1. Estimated power was calculated with the use of the standardized values obtained from the linear regression between the nutrient and BMD according to Luan et al (33). RESULTS APOE genotype Genotypes were in Hardy Weinberg equilibrium (SNP1 at position 112 X ; P 0.578; SNP2 at position 158 X2 0.90; P 0.343) with frequencies in descending order as follows: E3/E3 (n 1664), E3/E4 (n 619), E2/E3 (n 310), E2/E4 (n 62), E4/E4 (n 50), and E2/E2 (n 16). The allele frequencies were similar to those observed in other North European populations (3): E3 was 78.2%, E4 was 14%, and E2 was 7.8%. Subject characteristics The women who were genotyped for ApoE (n 2731) were not significantly different from women who were not genotyped (n 1150) in terms of BMD measurements and dietary energy intake, but they were marginally younger (x SD: y and y, respectively) and lighter ( kg and kg, respectively). No differences were observed in mean age, weight, height, and type of scanner used between carriers of the E2 allele, the E3/E3 genotype, and carriers of the E4 allele (Table 1). The characteristics of subjects who had one copy each of the E2 and E4 alleles (n 62) and who were excluded from further analysis were not significantly different from the other genotypes (data not shown). APOE associations with markers of bone health BMD at the second visit was greater for carriers of the E2 allele (LS: 1.03 g/cm 2 ; FN: 0.85 g/cm 2 ) than for carriers of the E4 allele (LS: 1.00 g/cm 2, FN: 0.83 g/cm 2 ), and there was less bone loss for carriers of the E2 allele (LS: 0.50%/y compared with 0.71%/y; FN: 0.63%/y compared with 0.79%/y) (Table 1). This was significant at the LS (ANOVA; P 0.04 for visit 2; P 0.05 for change in BMD) but not the FN (ANOVA; P 0.11 for visit 2; P 0.10 change in BMD). After adjustment for weight, height, smoking, socioeconomic status, menopausal status or HRT use, physical activity, and baseline BMD, the relation between APOE genotype and BMD was significant both at the spine (P 0.03) and the hip (P 0.04). No relation was observed between baseline BMD and APOE genotype. For the markers of bone turnover, the E3/E3 genotype was found to have significantly higher fdpd/creatinine (5.4 nmol/mmol) and fpyd/creatinine (19.5 nmol/ml) than carriers of the E2 allele (fdpd/ creatinine: 5.0 nmol/mmol; fpyd/creatinine: 18.7 nmol/mmol) and carriers of the E4 allele (fdpd/creatinine: 5.2 nmol/mmol; fpyd/creatinine: 18.7 nmol/mmol), but this relation was not significant after adjustment for confounders for fpyd/creatinine (Table 1). A trend was observed for lower concentrations of propeptide of type 1 collagen in the carriers of the E2 allele (33.6 g/l) than in carriers of the E4 allele (35.7 g/l) and the E3/E3 genotype (36.4 g/l) (P 0.07), but the relation was not significant after adjustment for confounders (P 0.17).

4 1516 MACDONALD ET AL TABLE 1 Characteristics and measures of bone health according to apolipoprotein E (APOE) genotype 1 Genotype 2 E2/E2 or E2/E3 E3/E3 E4/E4 or E3/E4 P General characteristics 3 n (total: 2659) Time between visits (y) Age at baseline (y) Age at visit 2 (y) Weight at baseline (kg) Weight at visit 2 (kg) Height at baseline (cm) Height at visit 2 (cm) FN BMD at baseline (g/cm 2 ) FN BMD at visit 2 (g/cm 2 ) Change in FN BMD (%/y) Adjusted change in FN BMD (%/y) LS BMD at baseline (g/cm 2 ) LS BMD at visit 2 (g/cm 2 ) Change in LS BMD (%/y) Adjusted change in LS BMD (%/y) Markers of bone turnover 3 n (total: 2424) fdpd/cr (nmol/mmol) Adjusted fdpd/cr (nmol/mmol) fpyd/cr (nmol/mmol) Adjusted fpyd/cr (nmol/mmol) Marker of bone formation 6 n (total: 2366) P1NP ( g/l) Adjusted P1NP ( g/l) Vitamin K 3 n (total: 2413) Vitamin K 1 intake ( g/d) Scanned on XR36 scanner (%) Scanner and menopausal status 6 n (total: 2649) Menopausal status at baseline (%) 0.61 Premenopausal Perimenopausal Postmenopausal or HRT user HRT use at baseline (%) 0.99 None Past Present Menopausal status at visit 2 (%) 0.91 Premenopausal Perimenopausal Postmenopausal or HRT user HRT use at visit 2 (%) 0.21 None Past Present FN BMD, femoral neck bone mineral density; LS BMD, lumbar spine bone mineral density; fdpd/cr, free deoxypyridinoline crosslinks relative to creatinine; fpyd/cr, free pyridinoline crosslinks relative to creatinine; P1NP, N-terminal propeptide of type 1 collagen; HRT, hormone replacement therapy. Differences between genotypes were tested by one-factor ANOVA with variables being nl transformed except for change in BMD. 2 Excluded APOE2/E4 (n 62). 3 P value determined with ANOVA. 4 x SD (all such values). 5 Adjusted for weight, height, smoking, socioeconomic status, physical activity, and menopausal status or HRT use (and baseline BMD bone loss for BMD change). 6 P value determined with the chi-square test.

5 APOE, VITAMIN K, AND BMD IN POSTMENOPAUSAL WOMEN 1517 TABLE 2 Differences in bone markers according to quartile (Q) of energy-adjusted intake of vitamin K 1 at visit 2 1 Q1 Q2 Q3 Q4 P 2 General characteristics n (total: 3199) Energy-adjusted vitamin K 1 intake ( g/d) Actual vitamin K 1 intake ( g/d) FN BMD at baseline (g/cm 2 ) FN BMD at visit 2 (g/cm 2 ) a a b a,b Adjusted FN BMD at visit 2 (g/cm 2 ) Change in FN BMD (%/y) LS BMD at baseline (g/cm 2 ) LS BMD at visit 2 (g/cm 2 ) a,b a b a,b Adjusted LS BMD at visit 2 (%/y) Change in LS BMD (%/y) Markers of bone turnover (visit 2 only) n (total: 2913) fdpd/cr (nmol/mmol) a a,b a,b b Adjusted fdpd/cr (nmol/mmol) fpyd/cr (nmol/mmol) a a,b a,b b Adjusted fpyd/cr (nmol/mmol) Marker of bone formation n (total: 2466) P1NP ( g/l) FN BMD, femoral neck bone mineral density; LS BMD, lumbar spine bone mineral density; fdpd/cr, free deoxypyridinoline crosslinks relative to creatinine; fpyd/cr, free pyridinoline crosslinks relative to creatinine; P1NP, N-terminal propeptide of type 1 collagen. Differences between quartiles of energy-adjusted intake of vitamin K 1 were tested by one-factor ANOVA. Values in the same row with different superscript letters differ significantly, P 0.05 (Scheffe s post hoc ANOVA). 2 nl Transformed (for all variables except change in BMD). 3 x SD (all such values). 4 Adjusted for weight, height, smoking, socioeconomic status, physical activity, and menopausal status or hormone replacement therapy use. Vitamin K For the subset of women that completed the FFQ on both occasions (n 898), no change was observed in mean ( SD) vitamin K 1 intakes between baseline ( g/d) and visit 2 ( g/d; P 0.31). The vitamin K 1 intake of the women who completed the FFQ at the second visit only was significantly greater at g/d (P 0.01). This may be explained by the former group being younger (mean age at baseline: y compared with y; P 0.01) because the women were selected because they were premenopausal and also had no medical condition and were not taking any medication known to affect bone metabolism. When the groups were combined, mean daily vitamin K 1 intake (at visit 2) was g, ranging from 8 g to494 g. Vitamin K 1 and markers of health A significant association was observed between energyadjusted intake of vitamin K 1 and both BMD and markers of bone resportion (Table 2). BMD was found to be lower in the lowest quartile of energy-adjusted intake of vitamin K 1 (daily vitamin K 1 intake: g, energy-adjusted intake; g, actual) than in the upper quartiles of vitamin K 1 intake [daily vitamin K 1 intake, quartile 3 (Q3): g energy-adjusted, g actual; Q4: g energy-adjusted, g actual] (ANOVA; second visit: P 0.01 for FN BMD; P 0.01 for LS BMD). Scheffe post hoc analysis showed significant differences between Q1 ( g/cm 2 ) and Q3 ( g/cm 2 )(P 0.01) and between Q2 ( g/cm 2 ) and Q3 (P 0.01) for FN and between Q2 ( g/cm 2 ) and Q3 ( g/cm 2 )(P 0.04) for LS. The same findings were observed if women who were scanned on the XR36 scanner were excluded or if women on warfarin treatment were excluded. The results were significant after adjustment for the following confounders: age, weight, height, smoking, socioeconomic status, menopausal status and use of HRT, and PAL at the hip but not at the spine (analysis of covariance; P 0.04 for FN BMD; P 0.38 for LS BMD) (Table 2). With linear regression analysis, adjusting for confounders, energy-adjusted intake of vitamin K 1 as a continuous variable was not found to be a predictor of either LS or FN BMD. Weight accounted for most of the variation of BMD (13.5%) followed by menopausal status (1.4%). For LS BMD, again, weight was the major predictor (11.3%) with menopausal status accounting for a further 3.7% variation. In total, the variables we tested accounted for 17 18% of the total variation of BMD. Bone resorption markers were significantly higher in the lowest quartile of energy-adjusted intake of vitamin K 1 (fdpd/creatinine: nmol/mmol; fpyd/creatinine: nmol/mmol) than in the highest quartile (fdpd/creatinine: nmol/mmol; fpyd/creatinine: nmol/mmol) (Scheffe post hoc analysis; P for fdpd/creatinine and P for fpyd/creatinine) (Table 2), and the difference remained significant after adjustment for confounders. Linear regression showed that energy-adjusted intake of vitamin K 1 predicted 2.7% of the variation of fdpd/creatinine and 2.1% of the variation in fpyd/creatinine. The other predictors for fdpd/ creatinine were menopausal status or HRT use (9.9%), weight (2.7%), height (1.4%), and smoking (0.3%), and predictors for

6 1518 MACDONALD ET AL fpyd/creatinine were menopausal status or HRT use (12.0%), weight (2.1%), height (1.1%), and smoking (0.3%). Interaction between APOE and vitamin K 1 No interaction was found between APOE genotype and dietary intake of vitamin K 1 in regulating BMD or bone loss (BMD change: P 0.76 for LS; P 0.16 for FN). Postanalysis power was determined after excluding E2/E4 genotypes by comparing standardized values between FN BMD change and energyadjusted intake of vitamin K 1 for carriers of the E2 allele and noncarriers of the E2 allele. For carriers of the E2 allele, the relation between FN BMD change and energy-adjusted intake of vitamin K 1 was weakly positive (standardized : 0.065), whereas for noncarriers of the E2 allele the relation was weakly negative (standardized : 0.023). Power was calculated as 31.9% at the 5% significance level. DISCUSSION In previous studies the apolipoprotein E4 allele was associated with increased fracture risk in older men and women (34) and patients receiving hemodialysis (35) and was associated with lower BMD in men only but not women (36). In this population of early postmenopausal women, carriers of the E2 allele of the APOE polymorphism had the highest BMD at the second visit and carriers of the E4 allele had the lowest BMD, which was a result of less bone loss occurring in the E2 group than in the E4 carriers. No association was observed between APOE genotype and BMD at the baseline visit, indicating that any influence of the APOE genotype was not on peak bone mass. After adjustment for confounders, the level of significance of the tests with BMD did not reach the lower threshold required by multiple independent testing. It is possible that nutrient interaction may mask a clearcut association. However, our data suggest that vitamin K 1 associations on bone health operate by a different mechanism from the trends seen with APOE. The association was between vitamin K 1 and BMD (visit 2 and baseline) and bone markers and was not with a change in BMD. A 3-y vitamin K intervention study in healthy postmenopausal women saw a benefit at the FN only and no influence at the LS, which is consistent with our data (37). In a depletion-repletion study phylloquinone (vitamin K 1 ) did not produce a marked effect on bone metabolism, although 450 g (5 7 times adequate intake) resulted in a decrease in the bone resorption marker urine N-terminal telopeptide (38). We observed a significant difference in deoxypyridinoline markers between women with a low mean daily intake of vitamin K 1 (59 g) and women with a high mean intake (162 g). For BMD, women with a low mean intake of vitamin K 1 (59 g/d) had a lower BMD than did women with a higher mean intake (116 g/d), but BMD did not increase further for higher concentrations of vitamin K 1 (mean intake: 162 g/d). This, together with the observation that vitamin K 1 as a continuous variable was not found to be a significant predictor of BMD, may suggest a threshold effect for this nutrient. A recent Danish study found no association between vitamin K 1 intake and BMD or fracture risk in 1139 perimenopausal and postmenopausal women in whom mean intakes were estimated to be 60 g/d (39). Although the scale of our findings was small, as is often the case for nutritional factors (2 3% BMD difference between Q1 and Q3 of vitamin K), it was 15% of the SD in BMD for this population. It is known that a 0.5-SD difference in BMD, if maintained into old age, could reflect a 30% reduction in fractures. Similarly, vitamin K intake accounted for 2 3% of the total variation in bone resorption markers, and there was a 5% difference in BMD between Q1 and Q4. We consider that the size of the effect, although modest, was biologically meaningful. A study examining both British and Chinese populations found that the E4 allele was associated with higher plasma concentrations of vitamin K 1 (and also lower concentrations of undercarboxylated osteocalcin in the Chinese population) compared with E2/3 or E3/3 genotypes (21). The mean daily intake of vitamin K 1 in their UK population (103 g) was similar to the mean intake in our study (107 g), whereas vitamin K 1 intake in their Chinese population was more than twice as much (247 g/d). If, as has been hypothesized, the ApoE gene influences transport of vitamin K 1, their study would indicate that E4 carriers had the advantage for bone health. This is the opposite of our own findings, whereby we found the E2 allele to be associated with reduced bone loss and again suggests that the influences of APOE and vitamin K on bone health are likely to be independent. The sample size in the study by Yan et al (21) was small (n 132 in the United Kingdom; n 177 in China) and included men and women, and it is possible that there may be sex differences in how APOE affects circulating vitamin K 1. We found no significant interaction between the ApoE genotype and vitamin K 1 on BMD, although it is recognized that this analysis may be limited in terms of power. The observation that vitamin K 1 and the APOE genotype affect different phenotypes (predominantly affecting different bone sites) and the trend observed with the APOE genotype was with bone loss, whereas for vitamin K 1 it was with BMD and bone markers, suggest that the mechanisms behind the associations with markers of bone health are different for the APOE genotype and vitamin K 1 intake. If nutrient interaction has masked the association of APOE with bone health, our data would not support that it is through vitamin K transport. Alternative hypotheses that could be explored include ApoE effects mediated through transport of fats or fatsoluble vitamins other than vitamin K such as vitamin A or vitamin D. As with all observational studies that investigate diet, there will be some correlation between nutrients, and it is possible that vitamin K 1 is simply a marker of green vegetable or overall nutritional intake. We previously reported an association with net endogenous acid production and BMD in premenopausal but not in early postmenopausal women (22). Prynne et al (40) found that fruit and vegetable intake was associated with the sizeadjusted bone mineral content in postmenopausal women and concluded that it was not due to the acidity generated by the diet. We would concur that further research is required to determine which component in fruit and vegetables is responsible for better bone health. A limitation of our study is that, because of its large size (essential for determining genetic effects on BMD), volunteers were seen throughout the day, and it was not possible to collect blood samples at a fixed time of day. The timing of sampling is crucial for measurements that are dependent on circadian rhythm, and, consequently, we have no measurements of circulating vitamin K or estimates of the ratio of carboxylated to undercarboxylated osteocalcin. A recent study of postmenopausal women in Ireland found that vitamin K 1 was inversely

7 APOE, VITAMIN K, AND BMD IN POSTMENOPAUSAL WOMEN 1519 related to undercarboxylated osteocalcin (41). That study found that the mean daily intake from food was 107 g (with 44% coming from broccoli, cabbage, and lettuce), which is comparable to the mean intake of vitamin K 1 of the women in our study. A further limitation of our study is that we have only estimated vitamin K 1. Evidence suggests that hydrogenation of vegetable oils produces a form of vitamin K that is not as well absorbed and is less active, which could influence the estimate of vitamin K obtained from spreadable fats (42). We do not have estimates of vitamin K 2, although intakes of vitamin K 2 are likely to be low in our population. In populations in which intakes of vitamin K 2 are higher, through greater consumption of fermented foods (eg, in Japanese diets), these intakes still fall short of the amounts used in the vitamin K intervention studies that are published (up to several thousand-fold of what would be found in a normal diet) (13). In conclusion, in this large cohort of well-characterized early postmenopausal women, dietary intake of vitamin K 1 was associated with several markers of bone health. No interaction was observed between dietary vitamin K and APOE alleles on BMD or biochemical markers of bone turnover. Although advice about dietary guidelines is premature, these data add to the evidence that a healthy diet, which includes green vegetables, would appear to benefit bone. We thank Martin Shearer and Caroline Bolton Smith with regard to the provision of the UK vitamin K database, Antonia Hardcastle for assistance with estimating dietary vitamin K, and N Hoyle (Roche) for the reagents for propeptide of type 1 collagen measurements. We thank Dr Luan for the SPSS version of power calculation for gene-nutrient interaction. We are also extremely grateful for the hard work of the radiographers and research nurses at the Osteoporosis Research Unit and to all the women who kindly participated in the study. The author s responsibilities were as follows HMM: carried out the study, analyzed the data, and wrote the manuscript; FEM: was responsible for the genotyping and wrote the manuscript; SAL-N: was involved in the design of the baseline dietary study and critically reviewed the manuscript; WDF: provided the bone marker results and critically reviewed the manuscript; SHR: gave advice on genetic aspects of the study, interpreted the data, and critically reviewed the manuscript; DMR: was responsible for the study design of APOSS and critically reviewed the manuscript. None of the authors had a financial or commercial interest in any company or organization sponsoring the research for this study. REFERENCES 1. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 2002;155: Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA. Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr 1999;69: Schoofs MW, van der Klift M, Hofman A, et al. ApoE gene polymorphisms, BMD, and fracture risk in elderly men and women: the Rotterdam study. J Bone Miner Res 2004;19: Booth SL, Tucker KL, Chen H, et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 2000;71: Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 1996;18: Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993;91: Hodges SJ, Pilkinton MJ, Stamp TC, et al. Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone 1991;12: Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF. Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Arch Intern Med 2006; 166: Douglas AS, Robins SP, Hutchison JD, Porter RW, Stewart A, Reid DM. Carboxylation of osteocalcin in post-menopausal osteoporotic women following vitamin K and D supplementation. Bone 1995;17: Jamal SA, Browner WS, Bauer DC, Cummings SR. Study of Osteoporotic Fractures Group. Warfarin use and risk for osteoporosis in elderly women. Ann Intern Med 1998;128: Department of Health. Dietary reference values for food energy and nutrients for the United Kingdom. London, United Kingdom: HMSO, Shearer MJ, Bach A, Kohlmeier M. Chemistry, nutritional sources, tissue distribution and metabolism of vitamin K with special reference to bone health. J Nutr 1996;126(suppl):1181S 6S. 13. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2006;166: Kohlmeier M, Salomon A, Saupe J, Shearer MJ. Transport of vitamin K to bone in humans. J Nutr 1996;126(suppl):1192S 6S. 15. Macdonald HM, New SA, Golden MH, Campbell MK, Reid DM. Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am J Clin Nutr 2004;79: Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr 1999;69: New SA, Bolton-Smith C, Grubb DA, Reid DM. Nutritional influences on bone mineral density: a cross-sectional study in premenopausal women. Am J Clin Nutr 1997;65: Wachman A, Bernstein DS. Diet and osteoporosis. Lancet 1968;i: Corella D, Tucker K, Lahoz C, et al. Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study. Am J Clin Nutr 2001;73: Ordovas JM, Corella D, Cupples LA, et al. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDLcholesterol concentrations in a sex-specific manner: the Framingham Study. Am J Clin Nutr 2002;75: Yan L, Zhou B, Greenberg D, et al. Vitamin K status of older individuals in northern China is superior to that of older individuals in the UK. Br J Nutr 2004;92: Macdonald HM, New SA, Fraser WD, Campbell MK, Reid DM. Low dietary potassium intakes and high dietary estimates of net endogenous acid production are associated with low bone mineral density in premenopausal women and increased markers of bone resorption in postmenopausal women. Am J Clin Nutr 2005;81: Black D, Duncan A, Robins SP. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase highperformance liquid chromatography. Anal Biochem 1988;169: MacDonald AG, Birkinshaw G, Durham B, Bucknall RC, Fraser WD. Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity. Br J Rheumatol 1997;36: Macdonald HM, McGuigan FE, Stewart A, et al. Large-scale population-based study shows no evidence of association between common polymorphism of the VDR gene and BMD in British women. J Bone Miner Res 2006;21: New SA. An epidemiological investigation into the influence of nutritional factors on bone mineral density and bone metabolism. PhD thesis. University of Aberdeen, Scotland, United Kingdom, Bodner CH, Soutar A, New SA, et al. Validation of a food frequency questionnaire for use in a Scottish population: correlation of antioxidant vitamin intakes with biochemical measures. J Hum Nutr Diet 1998;11: Macdonald HM, New SA, Reid DM. Longitudinal changes in dietary intake in Scottish women around the menopause: changes in dietary pattern result in minor changes in nutrient intake. Public Health Nutr 2005;8: Bolton-Smith C, Price RAG, Fenton ST, Harrington DJ, Shearer

8 1520 MACDONALD ET AL MJ. Compilation of a provisional UK database for the phylloquinone (vitamin K1) content of foods. Br J Nutr 2000;83: Tunstall-Pedoe H, Smith WC, Crombie IK, Tavendale R. Coronary risk factor and lifestyle variation across Scotland: results from the Scottish Heart Health Study. Scot Med J 1989;34: Department of Health. Dietary reference values for food energy and nutrients for the United Kingdom. London, United Kingdom: HMSO, Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65(suppl):1220S 8S. 33. Luan JA, Wong MY, Day NE, Wareham NJ. Sample size determination for studies of gene-environment interaction. Int J Epidemiol 2001;30: Johnston JM, Cauley JA, Ganguli M. APOE 4 and hip fracture risk in a community-based study of older adults. J Am Geriatr Soc 1999;47: Kohlmeier M, Saupe J, Schaefer K, Asmus G. Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype. Calcif Tissue Int 1998;62: Pluijm SM, Dik MG, Jonker C, et al. Effects of gender and age on the association of apolipoprotein E epsilon4 with bone mineral density, bone turnover and the risk of fractures in older people. Osteoporos Int 2002; 13: Braam LA, Knapen MH, Geusens P, et al. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int 2003;73: Martini LA, Booth SL, Saltzman E, do Rosario Dias de Oliveira Latorre M, Wood RJ. Dietary phylloquinone depletion and repletion in postmenopausal women: effects on bone and mineral metabolism. Osteoporos Int 2006;17: Rejnmark L, Vestergaard P, Charles P, et al. No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women. Osteoporos Int 2006;17: Prynne CJ, Mishra GD, O Connell MA, et al. Fruit and vegetable intakes and bone mineral status: a cross-sectional study in 5 age and sex cohorts. Am J Clin Nutr 2006;83: Collins A, Cashman KD, Kiely M. Phylloquinone (vitamin K1) intakes and serum undercarboxylated osteocalcin levels in Irish postmenopausal women. Br J Nutr 2006;95: Booth SL, Lichtenstein AH, O Brien-Morse M, et al. Effects of a hydrogenated form of vitamin K on bone formation and resorption. Am J Clin Nutr 2001;74:

Helen M Macdonald, Susan A New, William D Fraser, Marion K Campbell, and David M Reid

Helen M Macdonald, Susan A New, William D Fraser, Marion K Campbell, and David M Reid Low dietary potassium intakes and high dietary estimates of net endogenous acid production are associated with low bone mineral density in premenopausal women and increased markers of bone resorption in

More information

Vitamin K intake and bone mineral density in women and men 1 4

Vitamin K intake and bone mineral density in women and men 1 4 Vitamin K intake and bone mineral density in women and men 1 4 Sarah L Booth, Kerry E Broe, David R Gagnon, Katherine L Tucker, Marian T Hannan, Robert R McLean, Bess Dawson-Hughes, Peter WF Wilson, L

More information

NIH Public Access Author Manuscript Osteoporos Int. Author manuscript; available in PMC 2011 January 8.

NIH Public Access Author Manuscript Osteoporos Int. Author manuscript; available in PMC 2011 January 8. NIH Public Access Author Manuscript Published in final edited form as: Osteoporos Int. 2011 January ; 22(1): 345 349. doi:10.1007/s00198-010-1179-4. Does Dietary Protein Reduce Hip Fracture Risk in Elders?

More information

FRUIT AND VEGETABLE INTAKE IN POSTMENOPAUSAL WOMEN WITH OSTEOPENIA

FRUIT AND VEGETABLE INTAKE IN POSTMENOPAUSAL WOMEN WITH OSTEOPENIA FRUIT AND VEGETABLE INTAKE IN POSTMENOPAUSAL WOMEN WITH OSTEOPENIA Samira Ebrahimof, Anahita Hoshyarrad, Arash Hossein-Nezhad Nahid Zandi, Bagher Larijani, Masoud Kimiagar Abstract INTRODUCTION: Adequate

More information

provide alkaline metabolites, which could theoretically balance the excess acidity produced by eating a Westernized acidproducing

provide alkaline metabolites, which could theoretically balance the excess acidity produced by eating a Westernized acidproducing Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: a randomized controlled trial 1 4 Helen M Macdonald, Alison J Black,

More information

Additional Research is Needed to Determine the Effects of Soy Protein on Calcium Binding and Absorption NDFS 435 3/26/2015. Dr.

Additional Research is Needed to Determine the Effects of Soy Protein on Calcium Binding and Absorption NDFS 435 3/26/2015. Dr. Additional Research is Needed to Determine the Effects of Soy Protein on Calcium Binding and Absorption NDFS 435 3/26/2015 Dr. Tessem Osteoporosis is a public health problem in all stages of life. Many

More information

PAPER. HM Macdonald 1 *, SA New 2, MK Campbell 3 and DM Reid 1. Introduction

PAPER. HM Macdonald 1 *, SA New 2, MK Campbell 3 and DM Reid 1. Introduction (2003) 27, 669 676 & 2003 Nature Publishing Group All rights reserved 0307-0565/03 $25.00 www.nature.com/ijo PAPER Longitudinal changes in weight in perimenopausal and early postmenopausal women: effects

More information

Epidemiological evidence has shown associations between. Effect of Vitamin K Supplementation on Bone Loss in Elderly Men and Women

Epidemiological evidence has shown associations between. Effect of Vitamin K Supplementation on Bone Loss in Elderly Men and Women ORIGINAL ARTICLE Endocrine Care Effect of Vitamin K Supplementation on Bone Loss in Elderly Men and Women Sarah L. Booth, Gerard Dallal, M. Kyla Shea, Caren Gundberg, James W. Peterson, and Bess Dawson-Hughes

More information

nogg Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK

nogg Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK nogg NATIONAL OSTEOPOROSIS GUIDELINE GROUP Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK Produced by J Compston, A Cooper,

More information

Dietary intake in male and female smokers, ex-smokers, and never smokers: The INTERMAP Study

Dietary intake in male and female smokers, ex-smokers, and never smokers: The INTERMAP Study (2003) 17, 641 654 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Dietary intake in male and female smokers, ex-smokers, and never smokers: The

More information

Body Mass Index as Predictor of Bone Mineral Density in Postmenopausal Women in India

Body Mass Index as Predictor of Bone Mineral Density in Postmenopausal Women in India International Journal of Public Health Science (IJPHS) Vol.3, No.4, December 2014, pp. 276 ~ 280 ISSN: 2252-8806 276 Body Mass Index as Predictor of Bone Mineral Density in Postmenopausal Women in India

More information

Zinc Intake and Biochemical Markers of Bone Turnover in Type 1 Diabetes

Zinc Intake and Biochemical Markers of Bone Turnover in Type 1 Diabetes Diabetes Care Publish Ahead of Print, published online September 22, 2008 Zinc and bone markers Zinc Intake and Biochemical Markers of Bone Turnover in Type 1 Diabetes Raelene E. Maser, PhD 1,2; John N.

More information

Bone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome

Bone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome Bone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome Thomas et al. Nutrition Journal (2015) 14:99 DOI 10.1186/s12937-015-0092-2 RESEARCH Open Access Acute effect of a supplemented

More information

Fragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey

Fragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey Fragile Bones and how to recognise them Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey Osteoporosis Osteoporosis is a skeletal disorder characterised by compromised bone

More information

Index. B BMC. See Bone mineral content BMD. See Bone mineral density Bone anabolic impact, Bone mass acquisition

Index. B BMC. See Bone mineral content BMD. See Bone mineral density Bone anabolic impact, Bone mass acquisition A Acid base balance dietary protein detrimental effects of, 19 Acid base balance bicarbonate effects, 176 in bone human studies, 174 mechanisms, 173 174 in muscle aging, 174 175 alkali supplementation

More information

European Journal of Endocrinology (1997) ISSN

European Journal of Endocrinology (1997) ISSN European Journal of Endocrinology (1997) 137 167 171 ISSN 0804-4643 Change in C-terminal cross-linking domain of type I collagen in urine, a new marker of bone resorption, during and after gonadotropin-releasing

More information

9/26/2016. The Impact of Dietary Protein on the Musculoskeletal System. Research in dietary protein, musculoskeletal health and calcium economy

9/26/2016. The Impact of Dietary Protein on the Musculoskeletal System. Research in dietary protein, musculoskeletal health and calcium economy The Impact of Dietary Protein on the Musculoskeletal System Outline A. The musculoskeletal system and associated disorders Jessica D Bihuniak, PhD, RD Assistant Professor of Clinical Nutrition Department

More information

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study Rheumatol Int (2006) 26: 427 431 DOI 10.1007/s00296-005-0004-4 ORIGINAL ARTICLE J. D. Ringe Æ H. Faber Æ P. Farahmand Æ A. Dorst Efficacy of risedronate in men with primary and secondary osteoporosis:

More information

Genetic examination of diseases affecting bone development. and structure in newborns

Genetic examination of diseases affecting bone development. and structure in newborns Genetic examination of diseases affecting bone development and structure in newborns Examination of molecular genetic markers in osteopenic preterm infants PhD Thesis Simone Funke, MD University of Pécs

More information

Vitamin K2: Are You Consuming Enough? March 22, 2017 by Chris Kresser Abridged by Dr. Michael Schwarz

Vitamin K2: Are You Consuming Enough? March 22, 2017 by Chris Kresser Abridged by Dr. Michael Schwarz Vitamin K2: Are You Consuming Enough? March 22, 2017 by Chris Kresser Abridged by Dr. Michael Schwarz Did you know that vitamin K1 and vitamin K2 are different types of vitamin K? Before 2006, the USDA

More information

Men and Osteoporosis So you think that it can t happen to you

Men and Osteoporosis So you think that it can t happen to you Men and Osteoporosis So you think that it can t happen to you Jonathan D. Adachi MD, FRCPC Alliance for Better Bone Health Chair in Rheumatology Professor, Department of Medicine Michael G. DeGroote School

More information

Module 8 BONE HEALTH

Module 8 BONE HEALTH Module 8 BONE HEALTH 2012, Integrative 2015Nutrition, Integrative Inc. Nutrition, Inc. 2 BONE HEALTH Approximately 25 million people in the United States are effected by osteoporosis. 40% of women and

More information

WHAT KEEPS OUR BONES STRONG?

WHAT KEEPS OUR BONES STRONG? WHAT KEEPS OUR BONES STRONG? The role of diet and lifestyle in osteoporosis prevention Thomas Walczyk PhD, Associate Professor Food Science and Technology Programme Department of Chemistry, Faculty of

More information

British Journal of Nutrition

British Journal of Nutrition (2009), 102, 1477 1486 q The Authors 2009 doi:10.1017/s0007114509990377 Changes in vitamin biomarkers during a 2-year intervention trial involving increased fruit and vegetable consumption by free-living

More information

AMERICAN COLLEGE OF RHEUMATOLOGY POSITION STATEMENT. Committee on Rheumatologic Care

AMERICAN COLLEGE OF RHEUMATOLOGY POSITION STATEMENT. Committee on Rheumatologic Care AMERICAN COLLEGE OF RHEUMATOLOGY POSITION STATEMENT SUBJECT: PRESENTED BY: FOR DISTRIBUTION TO: Bone Mineral Density Measurement and the Role of Rheumatologists in the Management of Osteoporosis Committee

More information

Objectives: What is Osteoporosis 10/8/2015. Bone Health/ Osteoporosis: BASICS OF SCREENING, INTERPRETING, AND TREATING

Objectives: What is Osteoporosis 10/8/2015. Bone Health/ Osteoporosis: BASICS OF SCREENING, INTERPRETING, AND TREATING Bone Health/ Osteoporosis: BASICS OF SCREENING, INTERPRETING, AND TREATING TIFFANY PAUL, APN, CNP, CCD Objectives: Review the diagnosis of Osteoporosis Describe the basics of a bone density exam Identify

More information

The Relationship between Prevalence of Osteoporosis and Proportion of Daily Protein Intake

The Relationship between Prevalence of Osteoporosis and Proportion of Daily Protein Intake Korean J Fam Med. 2013;34:43-48 http://dx.doi.org/10.4082/kjfm.2013.34.1.43 The Relationship between Prevalence of Osteoporosis and Proportion of Daily Protein Intake Original Article Junga Kim, Byungsung

More information

Coordinator of Post Professional Programs Texas Woman's University 1

Coordinator of Post Professional Programs Texas Woman's University 1 OSTEOPOROSIS Update 2007-2008 April 26, 2008 How much of our BMD is under our control (vs. genetics)? 1 2 Genetic effects on bone loss: longitudinal twin study (Makovey, 2007) Peak BMD is under genetic

More information

Bone Mineral Density and Its Associated Factors in Naresuan University Staff

Bone Mineral Density and Its Associated Factors in Naresuan University Staff Naresuan University Journal 2005; 13(3): 13-18 13 Bone Mineral Density and Its Associated Factors in Naresuan University Staff Supawitoo Sookpeng *, Patsuree Cheebsumon, Malinee Dhanarun, Thanyavee Pengpan

More information

Effect of Precision Error on T-scores and the Diagnostic Classification of Bone Status

Effect of Precision Error on T-scores and the Diagnostic Classification of Bone Status Journal of Clinical Densitometry, vol. 10, no. 3, 239e243, 2007 Ó Copyright 2007 by The International Society for Clinical Densitometry 1094-6950/07/10:239e243/$32.00 DOI: 10.1016/j.jocd.2007.03.002 Original

More information

Correlation between Thyroid Function and Bone Mineral Density in Elderly People

Correlation between Thyroid Function and Bone Mineral Density in Elderly People IBBJ Spring 2016, Vol 2, No 2 Original Article Correlation between Thyroid Function and Bone Mineral Density in Elderly People Ali Mirzapour 1, Fatemeh Shahnavazi 2, Ahmad Karkhah 3, Seyed Reza Hosseini

More information

Supplementary Figures

Supplementary Figures Supplementary Figures Supplementary Fig 1. Comparison of sub-samples on the first two principal components of genetic variation. TheBritishsampleisplottedwithredpoints.The sub-samples of the diverse sample

More information

Consideration of Anthropometric Measures in Cancer. S. Lani Park April 24, 2009

Consideration of Anthropometric Measures in Cancer. S. Lani Park April 24, 2009 Consideration of Anthropometric Measures in Cancer S. Lani Park April 24, 2009 Presentation outline Background in anthropometric measures in cancer Examples of anthropometric measures and investigating

More information

Clinician s Guide to Prevention and Treatment of Osteoporosis

Clinician s Guide to Prevention and Treatment of Osteoporosis Clinician s Guide to Prevention and Treatment of Osteoporosis Published: 15 August 2014 committee of the National Osteoporosis Foundation (NOF) Tipawan khiemsontia,md outline Basic pathophysiology screening

More information

Study of secondary causes of male osteoporosis

Study of secondary causes of male osteoporosis Study of secondary causes of male osteoporosis Suárez, S.M., Giunta J., Meneses G., Costanzo P.R., Knoblovits P. Department of Endocrinology, Metabolism and Nuclear Medicine of Hospital Italiano of Buenos

More information

Section Editor Steven T DeKosky, MD, FAAN Kenneth E Schmader, MD

Section Editor Steven T DeKosky, MD, FAAN Kenneth E Schmader, MD Prevention of dementia Author Daniel Press, MD Michael Alexander, MD Section Editor Steven T DeKosky, MD, FAAN Kenneth E Schmader, MD Deputy Editor Janet L Wilterdink, MD Last literature review version

More information

Dietary Protein and Bone Health Emphasis: Animal Protein

Dietary Protein and Bone Health Emphasis: Animal Protein USDA-ARS Human Nutrition Research Centers Dietary Protein and Bone Health Emphasis: Animal Protein Z.K. (Fariba) Roughead, PhD, RD Research Nutritionist USDA-ARS Grand Forks Human Nutrition Research Center

More information

Understanding the potential of nutrigenomics/personalised nutrition to treat inflammation / CVD'

Understanding the potential of nutrigenomics/personalised nutrition to treat inflammation / CVD' Understanding the potential of nutrigenomics/personalised nutrition to treat inflammation / CVD' Anne-Marie Minihane Prof of Nutrigenetics, Department of Nutrition, Norwich Medical School, UEA, UK 1 CONTENT.

More information

Bone Density Measurement in Women

Bone Density Measurement in Women Bone Density Measurement in Women Revised 2005 Scope This guideline defines the medical necessity of bone mineral density (BMD) measurement using dualenergy x-ray absorptiometry (DXA or DEXA), and applies

More information

Is warfarin usage a risk factor for osteoporotic fractures? A cohort study in the emergency department

Is warfarin usage a risk factor for osteoporotic fractures? A cohort study in the emergency department Is warfarin usage a risk factor for osteoporotic fractures? A cohort study in the emergency department Genady Drozdinsky 1, Jonah B. Cohen 2, Zipora Shohat 3,4, Shachaf Shiber-Ofer 3,5, Alon Grossman 3,6

More information

Original Article APOE polymorphisms in connection with the susceptibility to osteoporotic fracture

Original Article APOE polymorphisms in connection with the susceptibility to osteoporotic fracture Int J Clin Exp Pathol 2016;9(3):3967-3971 www.ijcep.com /ISSN:1936-2625/IJCEP0020404 Original Article APOE polymorphisms in connection with the susceptibility to osteoporotic fracture Jinlei Sun 1,2*,

More information

The Better Health News2

The Better Health News2 October, 2016 Volume11, Issue 10 The Better Health News2 Special Interest Articles: Menopause and Bioflavonoids Osteoporosis and Exercise Bone Health: More than Calcium & Vitamin D Flax Seeds and Menopause

More information

Osteoporosis is a disease in which bones become fragile

Osteoporosis is a disease in which bones become fragile Preventing Osteoporosis the Bone Estrogen Strength Training Way by Linda B. Houtkooper, Ph.D., R.D., FACSM, Vanessa A. Stanford, M.S., R.D., CSCS, Lauve L. Metcalfe, M.S., FAWHP, Timothy G. Lohman, Ph.D.,

More information

Dr Tuan V NGUYEN. Mapping Translational Research into Individualised Prognosis of Fracture Risk

Dr Tuan V NGUYEN. Mapping Translational Research into Individualised Prognosis of Fracture Risk Dr Tuan V NGUYEN Bone and Mineral Research Program, Garvan Institute of Medical Research, Sydney NSW Mapping Translational Research into Individualised Prognosis of Fracture Risk From the age of 60, one

More information

Elecsys bone marker panel. Optimal patient management starts in the laboratory

Elecsys bone marker panel. Optimal patient management starts in the laboratory bone marker panel Optimal patient management starts in the laboratory Complete solution for osteoporosis The most complete bone metabolism panel on a single platform bone marker assays are important diagnostic

More information

Submission to the National Institute for Clinical Excellence on

Submission to the National Institute for Clinical Excellence on Submission to the National Institute for Clinical Excellence on Strontium ranelate for the prevention of osteoporotic fractures in postmenopausal women with osteoporosis by The Society for Endocrinology

More information

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients 2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type

More information

Bone density scanning and osteoporosis

Bone density scanning and osteoporosis Bone density scanning and osteoporosis What is osteoporosis? Osteoporosis occurs when the struts which make up the mesh-like structure within bones become thin causing them to become fragile and break

More information

K K MK-4 MK-4 1,25-D3

K K MK-4 MK-4 1,25-D3 22 5 13 D 25-Hydroxyvitamin D Gla K K D K D K K K -4MK-4 MK-4 MK-4 steriod and xenobiotic receptorsxr MK-4 SXR MK-4 K MK-4 D 1,25-D3 D 1 CYP27B1CYP27B1-KO D CYP27B1-KO D D CYP27B1-KO Ca 1,25-D3 D Vitamin

More information

Foods, nutrients and dietary patterns for healthy aging

Foods, nutrients and dietary patterns for healthy aging Foods, nutrients and dietary patterns for healthy aging Katherine L Tucker, PhD Professor of Nutritional Epidemiology University of Massachusetts Lowell Changes in dietary needs with aging Lower energy

More information

DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN

DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN October 2-4, Liverpool, UK EURO SPINE 2013 DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN D. Colangelo, L. A. Nasto, M. Mormando, E.

More information

New York State County Comparison of Fall-related Hip Fractures of Older Adults and Number of Dual-X-ray Absorptiometry Machines

New York State County Comparison of Fall-related Hip Fractures of Older Adults and Number of Dual-X-ray Absorptiometry Machines New York State County Comparison of Fall-related Hip Fractures of Older Adults and Number of Dual-X-ray Absorptiometry Machines Michael Bauer New York State Department of Health Bureau of Occupational

More information

Changes in Skeletal Systems over the Lifespan. Connie M. Weaver, Ph.D. Purdue University

Changes in Skeletal Systems over the Lifespan. Connie M. Weaver, Ph.D. Purdue University Changes in Skeletal Systems over the Lifespan Connie M. Weaver, Ph.D. Purdue University Disclosures Boards/Scientific Advisory Committees ILSI Showalter Pharmavite Grants NIH Dairy Research Institute Nestle

More information

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm Interpreting DEXA Scan and the New Fracture Risk Assessment Algorithm Prof. Samir Elbadawy *Osteoporosis affect 30%-40% of women in western countries and almost 15% of men after the age of 50 years. Osteoporosis

More information

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen

More information

Product: Denosumab (AMG 162) Clinical Study Report: month Primary Analysis Date: 21 November 2016 Page 1

Product: Denosumab (AMG 162) Clinical Study Report: month Primary Analysis Date: 21 November 2016 Page 1 Date: 21 November 2016 Page 1 2. SYNOPSIS Name of Sponsor: Amgen Inc., Thousand Oaks, CA, USA Name of Finished Product: Prolia Name of Active Ingredient: denosumab Title of Study: Randomized, Double-blind,

More information

Vitamin K intake and hip fractures in women: a prospective study 1 3

Vitamin K intake and hip fractures in women: a prospective study 1 3 Vitamin K intake and hip fractures in women: a prospective study 1 3 Diane Feskanich, Peter Weber, Walter C Willett, Helaine Rockett, Sarah L Booth, and Graham A Colditz ABSTRACT Background: Vitamin K

More information

Weighing in on Whole Grains: A review of Evidence Linking Whole Grains to Body Weight. Nicola M. McKeown, PhD Scientist II

Weighing in on Whole Grains: A review of Evidence Linking Whole Grains to Body Weight. Nicola M. McKeown, PhD Scientist II Weighing in on Whole Grains: A review of Evidence Linking Whole Grains to Body Weight Nicola M. McKeown, PhD Scientist II Weighing in on Whole Grains: A review of Evidence Linking Whole Grains to Body

More information

High Dietary Sodium Intake Assessed by 24-hour Urine Specimen Increase Urinary Calcium Excretion and Bone Resorption Marker

High Dietary Sodium Intake Assessed by 24-hour Urine Specimen Increase Urinary Calcium Excretion and Bone Resorption Marker J Bone Metab 214;21:189-194 http://dx.doi.org/1.115/jbm.214.21.3.189 pissn 2287-6375 eissn 2287-729 Original Article High Dietary Sodium Intake Assessed by 24-hour Urine Specimen Increase Urinary Calcium

More information

Development of the Eating Choices Index (ECI)

Development of the Eating Choices Index (ECI) Development of the Eating Choices Index (ECI) GK Pot 1, CJ Prynne 1, M Richards 2, AM Stephen 1 1 MRC Human Nutrition Research, Cambridge UK 2 MRC Unit for Lifelong Health and Ageing, London UK Background

More information

Osteoporosis is estimated to develop in 1 out of 4 women over the age of 50. Influence of bone densitometry results on the treatment of osteoporosis

Osteoporosis is estimated to develop in 1 out of 4 women over the age of 50. Influence of bone densitometry results on the treatment of osteoporosis Influence of bone densitometry results on the treatment of osteoporosis Nicole S. Fitt, * Susan L. Mitchell, * Ann Cranney, Karen Gulenchyn, Max Huang, * Peter Tugwell Abstract Background: Measurement

More information

New 2010 Osteoporosis Guidelines: What you and your health provider need to know QUESTIONS&ANSWERS

New 2010 Osteoporosis Guidelines: What you and your health provider need to know QUESTIONS&ANSWERS New 2010 Osteoporosis Guidelines: What you and your health provider need to know QUESTIONS&ANSWERS Wednesday, December 1, 2010 1:00 p.m. to 2:00 p.m. ET 1. I m 55 years old. I ve been taking Fosavance

More information

Collagen Crosslinks, Any Method

Collagen Crosslinks, Any Method 190.19 - Collagen Crosslinks, Any Method Collagen crosslinks, part of the matrix of bone upon which bone mineral is deposited, are biochemical markers the excretion of which provides a quantitative measurement

More information

Assessment of Nutritional Adequacy of Perimenopausal and Menopausal Working Women of Allahabad

Assessment of Nutritional Adequacy of Perimenopausal and Menopausal Working Women of Allahabad Assessment of Nutritional Adequacy of Perimenopausal and Menopausal Working Women of Allahabad Singh Pallavi *, Paul Virginia** & Prajapati Aditi *** * Research Scholar, Sam Higginbottom Institute of Agriculture,

More information

Sponsor / Company: sanofi-aventis and Proctor & Gamble Drug substance(s): Risedronate (HMR4003)

Sponsor / Company: sanofi-aventis and Proctor & Gamble Drug substance(s): Risedronate (HMR4003) These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: sanofi-aventis and

More information

Nutritional Aspects of Osteoporosis Care and Treatment Cynthia Smith, FNP-BC, RN, MSN, CCD Pars Osteoporosis Clinic, Belpre, Ohio

Nutritional Aspects of Osteoporosis Care and Treatment Cynthia Smith, FNP-BC, RN, MSN, CCD Pars Osteoporosis Clinic, Belpre, Ohio Osteoporosis 1 Nutritional Aspects of Osteoporosis Care and Treatment Cynthia Smith, FNP-BC, RN, MSN, CCD Pars Osteoporosis Clinic, Belpre, Ohio 1) Objectives: a) To understand bone growth and development

More information

Challenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA

Challenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Challenging the Current Osteoporosis Guidelines Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Whom to screen Which test How to diagnose Whom to treat Benefits

More information

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment William D. Leslie, MD MSc FRCPC Case #1 Age 53: 3 years post-menopause Has always enjoyed excellent health with

More information

Vitamin K status of healthy Japanese women: age-related vitamin K requirement for -carboxylation of osteocalcin 1 3

Vitamin K status of healthy Japanese women: age-related vitamin K requirement for -carboxylation of osteocalcin 1 3 Vitamin K status of healthy Japanese women: age-related vitamin K requirement for -carboxylation of osteocalcin 1 3 Naoko Tsugawa, Masataka Shiraki, Yoshitomo Suhara, Maya Kamao, Kiyoshi Tanaka, and Toshio

More information

Ca, Mg metabolism, bone diseases. Tamás Kőszegi Pécs University, Department of Laboratory Medicine Pécs, Hungary

Ca, Mg metabolism, bone diseases. Tamás Kőszegi Pécs University, Department of Laboratory Medicine Pécs, Hungary Ca, Mg metabolism, bone diseases Tamás Kőszegi Pécs University, Department of Laboratory Medicine Pécs, Hungary Calcium homeostasis Ca 1000g in adults 99% in bones (extracellular with Mg, P) Plasma/intracellular

More information

Changes in Bone Mineral Density and Metabolism in Women: Evaluation of bodily characteristics, bone metabolic markers and bone mineral density

Changes in Bone Mineral Density and Metabolism in Women: Evaluation of bodily characteristics, bone metabolic markers and bone mineral density Hiroshima J. Med. Sci. Vol. 62, No. 3, 49~53, September, 2013 HIJM 62 9 49 Changes in Bone Mineral Density and Metabolism in Women: Evaluation of bodily characteristics, bone metabolic markers and bone

More information

Diagnosis and Treatment of Osteoporosis. Department of Endocrinology and Metabolism Ajou University School of Medicine.

Diagnosis and Treatment of Osteoporosis. Department of Endocrinology and Metabolism Ajou University School of Medicine. Diagnosis and Treatment of Osteoporosis Department of Endocrinology and Metabolism Ajou University School of Medicine Yoon-Sok CHUNG WCIM, COEX, Seoul, 27Oct2014 Case 1 71-year old woman Back pain Emergency

More information

OSTEOPOROSIS: PREVENTION AND MANAGEMENT

OSTEOPOROSIS: PREVENTION AND MANAGEMENT OSTEOPOROSIS: OVERVIEW OSTEOPOROSIS: PREVENTION AND MANAGEMENT Judith Walsh, MD, MPH Departments of Medicine and Epidemiology and Biostatistics UCSF Definitions Key Risk factors Screening and Monitoring

More information

Osteoporosis. Overview

Osteoporosis. Overview v2 Osteoporosis Overview Osteoporosis is defined as compromised bone strength that increases risk of fracture (NIH Consensus Conference, 2000). Bone strength is characterized by bone mineral density (BMD)

More information

Osteoporosis/Fracture Prevention

Osteoporosis/Fracture Prevention Osteoporosis/Fracture Prevention NATIONAL GUIDELINE SUMMARY This guideline was developed using an evidence-based methodology by the KP National Osteoporosis/Fracture Prevention Guideline Development Team

More information

The omics approach in measuring the double burden of malnutrition

The omics approach in measuring the double burden of malnutrition IAEA Headquarter, Vienna, Austria, 3-5 October 2017 Joint IAEA-WHO-UNICEF workshop on analysis of biological pathways to better understand the double burden of malnutrition and to inform action planning

More information

Bone Densitometry. What is a Bone Density Scan (DXA)? What are some common uses of the procedure?

Bone Densitometry. What is a Bone Density Scan (DXA)? What are some common uses of the procedure? Scan for mobile link. Bone Densitometry What is a Bone Density Scan (DXA)? Bone density scanning, also called dual-energy x-ray absorptiometry (DXA) or bone densitometry, is an enhanced form of x-ray technology

More information

Association between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis by survey season

Association between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis by survey season University of Massachusetts Amherst From the SelectedWorks of Kalpana Poudel-Tandukar Summer August 19, 2009 Association between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis

More information

Prevalence Of Vitamin D Inadequacy In Peri And Postmenopausal Women Presented At Dow University Hospital, Ojha Campus. A Cross Sectional Study

Prevalence Of Vitamin D Inadequacy In Peri And Postmenopausal Women Presented At Dow University Hospital, Ojha Campus. A Cross Sectional Study ISPUB.COM The Internet Journal of Nutrition and Wellness Volume 12 Number 1 Prevalence Of Vitamin D Inadequacy In Peri And Postmenopausal Women Presented At Dow University S Shukar-ud-din, R Tabassum,

More information

Lipid Markers. Independent Risk Factors. Insulin Resistance Score by Lipid Fractionation

Lipid Markers. Independent Risk Factors. Insulin Resistance Score by Lipid Fractionation Patient: SAMPLE PATIENT DOB: Sex: MRN: 3701 CV Health Plus Genomics - Plasma, Serum & Buccal Swab Methodology: Chemiluminescent, Enzymatic, Immunoturbidimetric, NMR and PCR Lipid Markers Cholesterol LDL-

More information

To understand bone growth and development across the lifespan. To develop a better understanding of osteoporosis.

To understand bone growth and development across the lifespan. To develop a better understanding of osteoporosis. Nutrition Aspects of Osteoporosis Care and Treatment t Cynthia Smith, FNP-BC, RN, MSN, CCD Pars Osteoporosis Clinic, Belpre, OH. Objectives To understand bone growth and development across the lifespan.

More information

Collagen Crosslinks, Any Method

Collagen Crosslinks, Any Method 190.19 - Collagen Crosslinks, Any Method Collagen crosslinks, part of the matrix of bone upon which bone mineral is deposited, are biochemical markers the excretion of which provides a quantitative measurement

More information

BMD: A Continuum of Risk WHO Bone Density Criteria

BMD: A Continuum of Risk WHO Bone Density Criteria Pathogenesis of Osteoporosis Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis AGING MENOPAUSE OTHER RISK FACTORS RESORPTION > FORMATION Bone Loss LOW PEAK BONE MASS Steven T Harris

More information

Product: Denosumab (AMG 162) Synopsis Clinical Study Report: Date: 29 July 2008

Product: Denosumab (AMG 162) Synopsis Clinical Study Report: Date: 29 July 2008 Name of Sponsor: Amgen Inc., Thousand Oaks, CA Name of Finished Product: Denosumab (AMG 162) Name of Active Ingredient: Fully human monoclonal antibody to receptor activator for nuclear factor-κb ligand

More information

BONE HEALTH Dr. Tia Lillie. Exercise, Physical Activity and Osteoporosis

BONE HEALTH Dr. Tia Lillie. Exercise, Physical Activity and Osteoporosis BONE HEALTH Dr. Tia Lillie Exercise, Physical Activity and Osteoporosis Food for thought... How old would you be if you didn t know how old you were? DEFINITION: Osteoporosis Osteoporosis (OP) is a disease

More information

How can we tell who will fracture? Beyond bone mineral density to the new world of fracture risk assessment

How can we tell who will fracture? Beyond bone mineral density to the new world of fracture risk assessment Copyright 2008 by How can we tell who will fracture? Beyond bone mineral density to the new world of fracture risk assessment Dr. Bone density testing: falling short of expectations More than 25 years

More information

Dietary Fatty Acids and the Risk of Hypertension in Middle-Aged and Older Women

Dietary Fatty Acids and the Risk of Hypertension in Middle-Aged and Older Women 07/14/2010 Dietary Fatty Acids and the Risk of Hypertension in Middle-Aged and Older Women First Author: Wang Short Title: Dietary Fatty Acids and Hypertension Risk in Women Lu Wang, MD, PhD, 1 JoAnn E.

More information

An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines

An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines Osteoporos Int (2006) 17: 1111 1115 DOI 10.1007/s00198-006-0101-6 SHORT COMMUNICATION An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines R. Baddoura. H. Awada. J. Okais.

More information

696 Biomed Environ Sci, 2015; 28(9):

696 Biomed Environ Sci, 2015; 28(9): 696 Biomed Environ Sci, 2015; 28(9): 696-700 Letter to the Editor Fluoride Exposure, Follicle Stimulating Hormone Receptor Gene Polymorphism and Hypothalamus-pituitary-ovarian Axis Hormones in Chinese

More information

Nutrigenomics and Personalised Nutrition. John Hesketh

Nutrigenomics and Personalised Nutrition. John Hesketh Nutrigenomics and Personalised Nutrition How close is science-based evidence to support personalised nutrition? How best can these technical capabilities be put to use? John Hesketh Newcastle University

More information

A student carried out a series of food tests on a sample of milk. The student s observations and conclusions are shown in Table 1.1.

A student carried out a series of food tests on a sample of milk. The student s observations and conclusions are shown in Table 1.1. 1 (a) Milk is considered to be a complete food containing most of the components of a balanced diet. A student carried out a series of food tests on a sample of milk. The student s observations and conclusions

More information

Measurement of Fruit and Vegetable Consumption with Diet Questionnaires and Implications for Analyses and Interpretation

Measurement of Fruit and Vegetable Consumption with Diet Questionnaires and Implications for Analyses and Interpretation American Journal of Epidemiology Copyright ª 2005 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 161, No. 10 Printed in U.S.A. DOI: 10.1093/aje/kwi115 Measurement of Fruit

More information

Name of Policy: Zoledronic Acid (Reclast ) Injection

Name of Policy: Zoledronic Acid (Reclast ) Injection Name of Policy: Zoledronic Acid (Reclast ) Injection Policy #: 355 Latest Review Date: May 2011 Category: Pharmacy Policy Grade: Active Policy but no longer scheduled for regular literature reviews and

More information

Guideline for the investigation and management of osteoporosis. for hospitals and General Practice

Guideline for the investigation and management of osteoporosis. for hospitals and General Practice Guideline for the investigation and management of osteoporosis for hospitals and General Practice Background Low bone density is an important risk factor for fracture. The aim of assessing bone density

More information

S^t _j4 A-N.1^.^ A _ WE 2

S^t _j4 A-N.1^.^ A _ WE 2 S^t _j4 A-N.1^.^ A _ WE 2 Name of Sponsor: Amgen Inc. Name of Finished Product: Denosumab (AMG 162) Name of Active Ingredient: Fully human monoclonal antibody to RANKL Title of Study: A Randomized Study

More information

NEW MK-7 SELECT INTRODUCTION

NEW MK-7 SELECT INTRODUCTION NEW MK-7 SELECT INTRODUCTION As we have all known for several years now, the presence of optimal amounts of vitamin D is essential for maintaining optimal bone health and bone calcification, as noted by

More information

Bone loss in Postmenopausal former Unidepo users

Bone loss in Postmenopausal former Unidepo users Institute of Gerontology Bone loss in Postmenopausal former Unidepo users Fatemeh Mohammadi Prof.Tengku Aizan Hamid Prof.Mohd Nazri Yazid Dr. Zanariah Othman Prof. Rozi Mahmud Introduction One of the most

More information

Page: 1 of 12. Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated With High Bone Turnover

Page: 1 of 12. Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated With High Bone Turnover Last Review Status/Date: December 2014 Page: 1 of 12 Management of Osteoporosis and Diseases Description Bone turnover markers are biochemical markers of either bone formation or bone resorption. Commercially

More information

Osteoporosis Alternatives. James Biddle, MD

Osteoporosis Alternatives. James Biddle, MD Disclaimer This is simply an educational presentation and is not intended to diagnose or treat any individuals. Diagnosis and treatment of any disease should be done by a licensed healthcare practitioner

More information

Journal of Epidemiology Vol. 13, No. 1 (supplement) January 2003

Journal of Epidemiology Vol. 13, No. 1 (supplement) January 2003 Journal of Epidemiology Vol. 13, No. 1 (supplement) January 2003 Validity of the Self-administered Food Frequency Questionnaire Used in the 5-year Follow-Up Survey of the JPHC Study Cohort I: Comparison

More information